Efficacy of Birinapant in Combination with Carboplatin in Targeting Platinum-Resistant Epithelial Ovarian Cancers

A 3D organoid bioassay was utilized to test the efficacy of the combination therapy in a panel of seven epithelial ovarian cancer cell lines and ten platinum‑resistant primary patient tumor samples.